Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. Arv-110
2. 2222112-77-6
3. Bavdegalutamide [inn]
4. Bavdegalutamide [usan]
5. Arv110
6. H6nym0v650
7. 3-pyridazinecarboxamide, N-[trans-4-(3-chloro-4-cyanophenoxy)cyclohexyl]-6-[4-[[4-[2-(2,6-dioxo-3-piperidinyl)-6-fluoro-2,3-dihydro-1,3-dioxo-1h-isoindol-5-yl]-1-piperazinyl]methyl]-1-piperidinyl]-
8. N-(trans-4-(3-chloro-4-cyanophenoxy)cyclohexyl)-6-(4-((4-(2-(2,6-dioxopiperidin-3-yl)-6-fluoro-1,3-dioxoisoindolin-5-yl)piperazin-1-yl)methyl)piperidin-1-yl)pyridazine-3-carboxamide
9. 3-pyridazinecarboxamide, N-(trans-4-(3-chloro-4-cyanophenoxy)cyclohexyl)-6-(4-((4-(2-(2,6-dioxo-3-piperidinyl)-6-fluoro-2,3-dihydro-1,3-dioxo-1h-isoindol-5-yl)-1-piperazinyl)methyl)-1-piperidinyl)-
10. N-((1r,4r)-4-(3-chloro-4-cyanophenoxy)cyclohexyl)-6-(4-((4-(2-(2,6-dioxopiperidin-3-yl)-6-fluoro-1,3-dioxo-2,3-dihydro-1h-isoindol-5-yl)piperazin-1-yl)methyl)piperidin-1-yl)pyridazine-3-carboxamide
11. Starbld0008416
12. Unii-h6nym0v650
13. Arv-110 (protac)
14. Arv-110 [who-dd]
15. Chembl4862963
16. Schembl20046698
17. Gtpl11512
18. Ex-a5017
19. S6965
20. Who 11542
21. At25206
22. Ac-37002
23. As-84821
24. Compound 406 [wo2018071606a1]
25. Hy-138641
26. Cs-0159884
27. 6-[4-({4-[2-(2,6-dioxopiperidin-3-yl)-6-fluoro-1,3-dioxo-2,3-dihydro-1h-isoindol-5-yl]piperazin-1-yl}methyl)piperidin-1-yl]-n-[(1r,4r)-4-(3-chloro-4-cyanophenoxy)cyclohexyl]pyridazine-3-carboxamide
| Molecular Weight | 812.3 g/mol |
|---|---|
| Molecular Formula | C41H43ClFN9O6 |
| XLogP3 | 3.9 |
| Hydrogen Bond Donor Count | 2 |
| Hydrogen Bond Acceptor Count | 13 |
| Rotatable Bond Count | 9 |
| Exact Mass | 811.3008860 g/mol |
| Monoisotopic Mass | 811.3008860 g/mol |
| Topological Polar Surface Area | 181 Ų |
| Heavy Atom Count | 58 |
| Formal Charge | 0 |
| Complexity | 1590 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 1 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
Drugs in Development
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Digital Content
NEWS #PharmaBuzz
ABOUT THIS PAGE
A Bavdegalutamide manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Bavdegalutamide, including repackagers and relabelers. The FDA regulates Bavdegalutamide manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Bavdegalutamide API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Bavdegalutamide supplier is an individual or a company that provides Bavdegalutamide active pharmaceutical ingredient (API) or Bavdegalutamide finished formulations upon request. The Bavdegalutamide suppliers may include Bavdegalutamide API manufacturers, exporters, distributors and traders.
Bavdegalutamide Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Bavdegalutamide GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Bavdegalutamide GMP manufacturer or Bavdegalutamide GMP API supplier for your needs.
A Bavdegalutamide CoA (Certificate of Analysis) is a formal document that attests to Bavdegalutamide's compliance with Bavdegalutamide specifications and serves as a tool for batch-level quality control.
Bavdegalutamide CoA mostly includes findings from lab analyses of a specific batch. For each Bavdegalutamide CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Bavdegalutamide may be tested according to a variety of international standards, such as European Pharmacopoeia (Bavdegalutamide EP), Bavdegalutamide JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Bavdegalutamide USP).
LOOKING FOR A SUPPLIER?
